NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...

Cutting-edge centrifugation technology streamlines bacterial harvesting, DNA purification, and RNA synthesis for high-volume ...

Recently published data demonstrated that plasmid-free technology could produce over tenfold more AAV compared with a transient approach and particles which are 5- to 60-fold more infectious ...

The technology was first conceptualized at Colorado State University in 2018 and has since received support from CSU's Office of the Vice President for Research, the National Science Foundation ...

The CRISPR technology market is segmented by product type into Cas9 And gRNA, design tool, plasmid and vector, and other delivery system products. The Cas9 And gRNA market was the largest segment ...

Thursday, November 14th, 202411:00 AM - 12:30 PM ET Scientists use plasmids as the leading gene delivery technology for a variety of research and clinical applications related to gene therapy.

ZHENJIANG, China, Dec. 7, 2021/ PRNewswire/-- On December 7 th, the "Opening Ceremony of GenScript ProBio Plasmid Commercial GMP Manufacturing facility and Open Day" was rounded off.

IMUNON, Inc., a clinical-stage biotechnology company, announced that results from a Phase 1 clinical trial of its investigational DNA plasmid vaccine IMNN-101, based on its PlaCCine® technology ...

About OBiO Technology OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH) is a gene and cell therapy-focused CRO and CDMO founded in 2013.